You are here

• Home
• About AstraZeneca US
• Newsroom

• News

The following shows headlines of news articles, starting from most recent.

• Pages
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• Next

• • Feb 2, 2012
  • AstraZeneca PLC fourth quarter and full year results 2011  
• • Jan 20, 2012
  • AstraZeneca, United Way of Delaware kick off statewide Youth Health Initiative  
• • Jan 19, 2012
  • Bristol-Myers Squibb and AstraZeneca receive complete response letter from U.S. Food and Drug Administration for dapagliflozin  
• • Dec 7, 2011
  • AstraZeneca to streamline US Sales Organization  
• • Dec 5, 2011
  • Despite trend of therapeutic substitution, survey data shows patients want their physician to be the ultimate decision maker on their Rx medications  
• • Nov 21, 2011
  • AstraZeneca appoints Fante, McCourt to leadership roles in Americas  
• • Nov 15, 2011
  • SATURN demonstrated effect of intensive statin treatment on reducing atherosclerosis  
• • Nov 7, 2011
  • BRILINTA™ (ticagrelor) receives additional Class I recommendation in new U.S. Guidelines from ACCF/AHA/SCAI for PCI  
• • Nov 7, 2011
  • New CRESTOR® (rosuvastatin calcium) Savings Card Program provides instant savings to patients  
• • Nov 3, 2011
  • BRILINTA™ (ticagrelor) receives Class I recommendation in new US Guidelines from the American College of Cardiology Foundation and the American Heart Association  

• Pages
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• Next

Page tools

• Print
• Bookmark this page
• Subscribe to RSS news feed